No Data
No Data
No Data
No Data
No Data
Caribou Biosciences to Present Initial Dose Expansion Data From CB-010 ANTLER Phase 1 Trial in R/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
BERKELEY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced two abstract
Caribou BiosciencesApr 24 00:00 ET
Express News | Caribou Biosciences Announces Oral Presentation on in Vivo Cas12a Chrdna Genome Editing at the 27TH Annual Meeting of the American Society of Gene and Cell Therapy (Asgct)
Moomoo 24/7Apr 15 09:00 ET
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a ChRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
BERKELEY, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced an abstract
Caribou BiosciencesApr 15 00:00 ET
Buy Rating Affirmed: Caribou Biosciences' Promising Trials and Strategic Market Positioning
TipRanksApr 8 03:25 ET
Sector Update: Health Care Stocks Lean Higher Pre-Bell Friday
Health care stocks were leaning higher pre-bell Friday, with the Health Care Select Sector SPDR Fund (XLV) up 0.5% and the iShares Biotechnology ETF (IBB) flat recently. Nutex Health (NUTX) shares sli
MT NewswiresApr 5 08:57 ET
Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday. Shares of Kura Sushi USA, Inc. (NASDAQ:KRUS) climbed 6% to $110.11 in pre-market trading foll
BenzingaApr 5 08:01 ET
No Data
No Data